MHMax Healthcare Institute543220Ongoing legal dispute

NCLT Cuttack lists Kalinga Hospital petitions for further consideration on December 14, 2026

Max Healthcare's subsidiary Kalinga Hospital matter was heard by NCLT Cuttack on October 30, 2026.

By ScoutQuest · Tue 3 Nov 2026, 10:14 PM IST · 1 min read

NCLT Hearing Date

October 30, 2026

Next Listing Date

December 14, 2026

Order Copy Received

November 3, 2026 at 2.13 pm (IST)

What happened: A courtroom step, not a verdict

• Max Healthcare has informed the exchanges about the latest hearing in a set of petitions linked to its subsidiary, Kalinga Hospital Ltd (KHL).
• The petitions, including interlocutory petitions, were shared before the National Company Law Tribunal (NCLT), Cuttack Bench, by the legal representatives of BRS Capital Two Pte. Limited.
• The respondents named in the intimation are Kalinga Hospital Ltd, the other shareholder of KHL from whom Max Healthcare acquired the majority equity stake, and Max Healthcare itself.

The hearing and next date

• The matter was heard by the NCLT on October 30, 2026 at 2.30 pm (IST).
• Upon the request of all the counsels, the tribunal listed the matter for further consideration on December 14, 2026.
• Max Healthcare received a copy of the order on November 3, 2026 at 2.13 pm (IST).

What this means for a retail investor

• This is a status update on an ongoing legal proceeding. The matter has been scheduled for another round of consideration rather than concluded at this hearing.
• Kalinga Hospital Ltd is a subsidiary of the company, and the dispute involves the other shareholder from whom Max Healthcare acquired the majority equity stake, along with the company itself.
• The next date to track is December 14, 2026, when the tribunal is expected to take the matter up again.

How to read the update

• The intimation is a continuation of the company's earlier disclosure dated October 29, 2026 on the same petitions.
• It is a procedural development: a hearing took place and the matter has been listed for further consideration.
• Investors may note the respondents involved and the December 14, 2026 listing as the reference points for the dispute.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev